Table 2.
Receipt of selected cardiac medications and nonpharmacologic treatment regimens according to body mass index
| Body mass index (kg/m2) | ||||||
|---|---|---|---|---|---|---|
| <18.5 (n = 216) |
18.5–24.9 (n = 1465) |
25–29.9 (n = 1007) |
30–34.9 (n = 538) |
≥ 35 (n = 496) |
P value | |
| Medication (%) | ||||||
| ACE inhibitors/ARBs | 44.9 | 54.0 | 55.6 | 61.5 | 54.2 | <0.05 |
| Beta-blockers | 32.9 | 40.7 | 45.1 | 42.2 | 39.1 | 0.43 |
| Calcium channel blockers | 26.4 | 35.4 | 36.4 | 41.3 | 41.1 | <0.001 |
| Digoxin | 58.3 | 57.3 | 51.5 | 46.1 | 36.7 | <0.001 |
| Diuretics | 97.7 | 98.0 | 97.9 | 98.5 | 99.0 | 0.10 |
| Lipid-lowering medications | 3.2 | 12.9 | 18.2 | 19.3 | 18.4 | <0.001 |
| Nitrates | 60.7 | 66.7 | 68.2 | 70.1 | 59.9 | 0.45 |
| Lifestyle recommendations (%) | ||||||
| Fluid restriction | 18.5 | 22.1 | 20.8 | 23.8 | 28.8 | <0.01 |
| Increase physical activity | 36.6 | 42.6 | 43.4 | 42.1 | 40.1 | 0.94 |
| Low-fat diet | 41.7 | 57.6 | 61.5 | 67.1 | 63.3 | < 0.001 |
| Reduce alcohol consumption | 0.5 | 0.4 | 1.0 | 0.6 | 1.4 | <0.05 |
| Reduce salt intake | 71.8 | 81.5 | 81.6 | 86.1 | 85.5 | < 0.001 |
| Rehabilitation | 3.7 | 7.5 | 9.4 | 9.7 | 8.5 | <0.05 |
ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker.